Edesa Biotech Potential Upside
| EDSA Stock | | | USD 17.43 2.44 16.28% |
Potential Upside is the amount of upward price movement an investor or an analyst expects of a particular equity instrument. Below is Edesa Biotech's current Potential Upside with peer comparisons and related risk metrics.
Current Potential Upside Value
The Potential Upside of 53.86 for Edesa Biotech indicates significant estimated upside from current levels. Edesa Biotech's current price is well below the model-derived fair value estimate, though large gaps may also reflect model uncertainty.
Potential Upside | = | 1PM2PM |
| = | 53.86 | |
| 1PM | = | First upper moment |
| 2PM | = | Second upper moment |
Potential Upside Peers Comparison
Relative to peers, Edesa Biotech's Potential Upside is above the group average of 9.86. Peer readings range from 5.48 (Evogene) to 15.0 (BioRestorative Therapies), reflecting moderate dispersion across the sector. Edesa Biotech shows greater estimated upside from current levels than the peer average.
Potential Upside Relative To Other Indicators
The chart below plots Potential Upside against Maximum Drawdown for Edesa Biotech and its peers. Each point represents one equity — position along the horizontal axis shows Potential Upside while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Edesa Biotech's Maximum Drawdown of
106.25 runs about
1.97 times its Potential Upside of
53.86 . This indicates Maximum Drawdown moderately exceeds Potential Upside for Edesa Biotech.
Methodology, Assumptions & Data Sources
Edesa Biotech has a current Potential Upside reading of 53.86. The Potential Upside for Edesa Biotech applies a standardized calculation to daily closing prices and, where applicable, volume data across the selected period. The underlying data comes from exchange-reported daily closes with corporate action adjustments applied where relevant. Edesa Biotech operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Indicator accuracy depends on data continuity across the calculation period. Gaps in trading history may affect the output.
Other Technical Indicators